Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Influenza Vaccine in NHL Patients
NCT00307177Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2004
- Primary completion
- Apr 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2004; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00307177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307177.